Detalhe da pesquisa
1.
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy.
Int J Cancer
; 154(12): 2142-2150, 2024 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38447003
2.
[The use of immuno-oncologic therapy in hepatocellular carcinoma in the context of liver transplantation. An interdisciplinary benefit/risk assessment]. / Der Einsatz der immunonkologischen Therapie beim hepatozellulären Karzinom im Kontext der Lebertransplantation Eine interdisziplinäre Risiko-Nutzen-Abwägung.
Z Gastroenterol
; 60(2): 184-191, 2022 Feb.
Artigo
Alemão
| MEDLINE | ID: mdl-34670296
3.
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Lancet
; 393(10184): 1948-1957, 2019 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30982686
4.
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).
BMC Cancer
; 20(1): 503, 2020 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32487035
5.
Mutations in the plasma cell clone identify mechanism of polyneuropathy in a case of POEMS syndrome associated with Castleman disease and multiple myeloma.
Ann Hematol
; 102(1): 239-242, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36401620
6.
Measurement of piperacillin plasma concentrations in cancer patients with suspected infection.
Infection
; 45(5): 629-636, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28516432
7.
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
J Clin Oncol
; 42(4): 410-420, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37963317
8.
Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial.
JAMA Oncol
; 8(8): 1150-1158, 2022 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35737383
9.
CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach.
J Cancer Res Clin Oncol
; 144(3): 559-569, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-29285668